Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 7,423 | 6,976 | 6,535 | 7,208 | 7,176 | 6,768 | 7,315 | 6,618 | 6,270 | 6,455 | | 6,455 |
% Growth | NA | -6.0% | -6.3% | 10.3% | -0.4% | -5.7% | 8.1% | -9.5% | -5.3% | 2.9% | | |
| | | | | | | | | | | | |
Cost of Revenue | (5,741) | (5,309) | (4,953) | (5,430) | (5,340) | (5,096) | (5,428) | (4,881) | (4,571) | (4,696) | | (4,696) |
Gross Profit | 1,682 | 1,667 | 1,582 | 1,778 | 1,836 | 1,672 | 1,887 | 1,737 | 1,699 | 1,759 | | 1,759 |
% Revenue | 22.7% | 23.9% | 24.2% | 24.7% | 25.6% | 24.7% | 25.8% | 26.3% | 27.1% | 27.2% | | 27.2% |
| | | | | | | | | | | | |
Research and Development | (1) | (0) | (0) | (0) | (0) | (0) | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (1,340) | (1,290) | (1,273) | (1,323) | (1,378) | (1,378) | (1,384) | (1,189) | (1,144) | (1,217) | | (1,217) |
Other Inc / (Exp) | (335) | (321) | (295) | (340) | (423) | (510) | (425) | (335) | (385) | (483) | | (483) |
Total Operating Exp | (1,676) | (1,611) | (1,568) | (1,664) | (1,801) | (1,889) | (1,809) | (1,524) | (1,529) | (1,700) | | (1,700) |
| | | | | | | | | | | | |
Operating Income | 6 | 56 | 14 | 115 | 35 | (217) | 78 | 213 | 171 | 59 | | 59 |
% Revenue | 0.1% | 0.8% | 0.2% | 1.6% | 0.5% | -3.2% | 1.1% | 3.2% | 2.7% | 0.9% | | 0.9% |
| | | | | | | | | | | | |
Interest Expense | 7 | 4 | 6 | (0) | (11) | (20) | (12) | 2 | 13 | 9 | | 9 |
Pre-tax Income | 13 | 60 | 20 | 115 | 23 | (237) | 66 | 216 | 184 | 67 | | 67 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 25 | 150 | 0 | 0 | 0 | 20 | | 20 |
Provision for Taxes | (2) | (11) | (33) | (90) | (37) | (35) | (49) | (38) | (9) | (5) | | (5) |
Net Income to Company | 11 | 49 | (13) | 24 | 12 | (122) | 17 | 178 | 175 | 82 | | 82 |
% Margin | 0.1% | 0.7% | -0.2% | 0.3% | 0.2% | -1.8% | 0.2% | 2.7% | 2.8% | 1.3% | | 1.3% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (1) | (2) | (1) | (1) | (0) | 0 | 1 | 2 | 0 | 0 | | 0 |
Net Income to Stockholders | 10 | 47 | (14) | 24 | 12 | (122) | 18 | 180 | 175 | 82 | | 82 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | (25) | (150) | 0 | 0 | 0 | (20) | | (20) |
| | | | | | | | | | | | |
Net Income to Common | 10 | 47 | (14) | 24 | (13) | (272) | 18 | 180 | 175 | 62 | | 62 |
% Margin | 0.1% | 0.7% | -0.2% | 0.3% | -0.2% | -4.0% | 0.2% | 2.7% | 2.8% | 1.0% | | 1.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.04 | 0.17 | (0.05) | 0.09 | (0.05) | (0.99) | 0.07 | 0.66 | 0.65 | 0.23 | | 0.23 |
Diluted EPS (Continuing Ops) | 0.04 | 0.17 | (0.05) | 0.09 | (0.05) | (1.00) | 0.07 | 0.65 | 0.64 | 0.23 | | 0.23 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 270.96 | 270.50 | 272.22 | 273.49 | 273.50 | 273.30 | 273.30 | 271.78 | 269.97 | 268.97 | | 268.97 |
WA Diluted Shares Out. | 270.96 | 283.64 | 272.22 | 273.49 | 273.50 | 273.30 | 284.46 | 275.56 | 274.34 | 270.60 | | 270.60 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 13 | 60 | 20 | 115 | 23 | (237) | 66 | 216 | 184 | 67 | | 67 |
Addback: Net Interest Expense | (7) | (4) | (6) | 0 | 11 | 20 | 12 | (2) | (13) | (9) | | (9) |
Addback: Other Non Operating Expenses, Total | (20) | (25) | (24) | (50) | (11) | 6 | (53) | (54) | (18) | 61 | | 61 |
Addback: Depreciation & Amortization | 67 | 61 | 56 | 66 | 55 | 54 | 53 | 41 | 40 | 43 | | 43 |
Addback: Restructuring Charges | 39 | 34 | 0 | 4 | 5 | 45 | 6 | 4 | 10 | 12 | | 12 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 3 | 0 | 0 | 0 | 0 | 61 | 0 | 7 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (3) | (0) | 0 | 3 | (3) | 2 | 14 | 2 | (2) | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (5) | (6) | (5) | (2) | 0 | 0 | 19 | (55) | (2) | (1) | | (1) |
Addback: Asset Writedown | 1 | 51 | 4 | 22 | 10 | 1 | 10 | (0) | 0 | 7 | | 7 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (3) | (42) | 0 | 11 | 0 | (1) | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 87 | 128 | 46 | 168 | 91 | (50) | 127 | 157 | 199 | 180 | | 180 |
% Margin | 1.2% | 1.8% | 0.7% | 2.3% | 1.3% | -0.7% | 1.7% | 2.4% | 3.2% | 2.8% | | 2.8% |
| | | | | | | | | | | | |
Adjusted EBIT | 19 | 67 | (10) | 103 | 36 | (104) | 75 | 116 | 159 | 137 | | 137 |
% Margin | 0.3% | 1.0% | -0.1% | 1.4% | 0.5% | -1.5% | 1.0% | 1.8% | 2.5% | 2.1% | | 2.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 11 | 49 | (13) | 24 | 12 | (122) | 17 | 178 | 175 | 82 | | 82 |
Addback: Unusual Items | 33 | 36 | 0 | 38 | 13 | 107 | 49 | (43) | 7 | 18 | | 18 |
Less: Tax Benefit of Unusual Items (26%) | (9) | (9) | (0) | (10) | (3) | (28) | (13) | 11 | (2) | (5) | | (5) |
Adjusted Net Income | 35 | 76 | (13) | 52 | 21 | (43) | 53 | 146 | 180 | 96 | | 96 |
% Margin | 0.5% | 1.1% | -0.2% | 0.7% | 0.3% | -0.6% | 0.7% | 2.2% | 2.9% | 1.5% | | 1.5% |